Concepedia

Author

R Mahon

Novartis (Ireland)ORCID

Also Known As

Mahon R, Mahon, Ronan, R MAHON, R Mahon, R. Mahon, Ronan Mahon

42

Publications

111

Citations

5

H-Index

21

Concepts

All Affiliations

Novartis (Ireland)
RM

About

R Mahon is an author at Novartis (Ireland) specializing in health sciences, neurology, and cost-benefit analysis.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Business

1

1

25

2

Engineering

1

1

25

3

Health Sciences

1

1

33

4

Medicine

1

1

33

5

Economics

1

1

25

R Mahon

×

3

Publications

69

Citations

3

H-Index

YearCitations

Cost-Effectiveness of Erenumab for the Preventive Treatment of Migraine in Patients with Prior Treatment Failures in Sweden

R Mahon, A Lang, Pamela Vo,

PharmacoEconomics

2021

33

How to Appropriately Extrapolate Costs and Utilities in Cost-Effectiveness Analysis

Laura Bojke, Andrea Manca, Miqdad Asaria,

PharmacoEconomics

2017

25

Cost-utility of ranibizumab versus aflibercept for treating Greek patients with visual impairment due to diabetic macular edema

Georgia Kourlaba, John Relakis, R Mahon,

Cost Effectiveness and Resource Allocation

2016

11

Page 1